Pionneau, C. | bioRxiv Science

bioRxiv2021

The Autophagy Receptor TAX1BP1 (T6BP) is a novel player in antigen presentation by MHC-II molecules.

CD4+ T lymphocytes play a major role in the establishment and maintenance of immunity. They are activated by antigenic peptides derived from extracellular or newly synthesized (endogenous) proteins presented on the surface of antigen presenting cells (APCs) by the MHC-II molecules. The pathways leading to endogenous MHC-II presentation remain poorly characterized. We demonstrate here that the autophagy receptor, T6BP, influences both autophagy-dependent and -independent endogenous presentation of HIV- and HCMV-derived peptides. By studying the immunopeptidome of MHC-II molecules, we show that T6BP affects both the quantity and quality of peptides presented. T6BP silencing induces the mislocalization of the MHC-II-loading compartments and a rapid degradation of the invariant chain (CD74) without altering the expression and internalization kinetics of MHC-II molecules. We determined the interactome of T6BP, identified calnexin as a T6BP partner and show that CANX cytosolic tail is required for this interaction. Remarkably, calnexin silencing replicates the functional consequences of T6BP silencing: decreased CD4+ T cell activation and exacerbated CD74 degradation. Altogether, we unravel T6BP as a key player of the MHC-II-restricted endogenous presentation pathway and we propose one potential mechanism of action.

immunology↗

bioRxiv2020

In-depth proteomic analysis of Plasmodium berghei sporozoites using trapped ion mobility spectrometry with parallel accumulation-serial fragmentation

Malaria is caused by Plasmodium spp. protozoan parasites, which are transmitted by female anopheline mosquitoes in the form of sporozoites. Once deposited in the dermis during the blood meal of the mosquito, sporozoites rapidly migrate to the liver for an initial and obligatory round of replication inside hepatocytes, before exponential multiplication of the parasite in the blood and onset of the malaria disease. Sporozoites and liver stages provide attractive targets for the development of a malaria vaccine. Until now, a single antigen from Plasmodium falciparum, the deadliest species infecting humans, has been considered for subunit vaccine clinical development, with limited success so far. This emphazises the need to identify novel targets. In this context, defining the parasite proteome is important not only to guide the down-selection of potential candidate antigens, but also to allow a better understanding of the parasite biology. Previous studies have determined the total proteome of sporozoite stages from the two main human malaria parasites, P. falciparum and P. vivax, as well as P. yoelii, a parasite that infects rodents. Another murine malaria parasite, P. berghei, has been widely used to investigate the biology of Plasmodium pre-erythrocytic stages. However, a deep view of the proteome of P. berghei sporozoites is still missing. To fill this gap, we took advantage of a novel highly sensitive timsTOF PRO mass spectrometer, based on trapped ion mobility spectrometry with parallel accumulation-serial fragmentation. Combined with three alternative methods for sporozoite purification, this approach allowed us to identify the deep proteome of P. berghei sporozoites using low numbers of parasites. This study provides a reference proteome for P. berghei sporozoites, identifying a core set of proteins expressed accross species, and illustrates how the unprecedented sensitivity of the timsTOF PRO system enables deep proteomic analysis from limited sample amounts.

microbiology↗